In Q4 of fiscal 2024, the quarter ended Dec 31, 2024, Sonendo, Inc. reported revenue of $8.3 million, down 8.0% from the same quarter a year earlier. It recorded a net loss of $6.4 million. The operating loss came to $5.6 million, an operating margin of -67.9%. Diluted earnings per share were -$13.44.
USD in millions, except per-share amounts and margins. The percent under a figure is the change from the same quarter a year earlier.
| Line |
Q4 FY2024
Dec 31, 2024
|
Q3 FY2024
Sep 30, 2024
|
Q2 FY2024
Jun 30, 2024
|
Q1 FY2024
Mar 31, 2024
|
Q4 FY2023
Dec 31, 2023
|
Q3 FY2023
Sep 30, 2023
|
Q2 FY2023
Jun 30, 2023
|
Q1 FY2023
Mar 31, 2023
|
|---|---|---|---|---|---|---|---|---|
| Revenue |
8
-8.0%
|
8
-1.6%
|
8
-5.1%
|
7
-18.8%
|
9
-26.2%
|
8
-17.1%
|
9
-16.9%
|
9
-3.9%
|
| Cost of revenue |
5
-27.4%
|
5
-35.1%
|
5
-47.7%
|
5
-24.7%
|
7
-24.4%
|
7
-3.3%
|
10
+24.4%
|
7
-0.8%
|
| Gross profit |
3
+49.0%
|
3
+274.4%
|
3
+742.5%
|
2
+1.2%
|
2
-31.2%
|
1
-61.9%
|
-0
-119.0%
|
2
-13.2%
|
| Research and development |
1
-28.1%
|
2
-43.0%
|
2
-43.3%
|
2
-25.2%
|
2
-45.1%
|
3
-35.6%
|
3
-31.2%
|
3
-39.6%
|
| Selling, general and administrative |
8
-31.6%
|
9
-36.7%
|
8
-44.2%
|
10
-28.7%
|
11
-23.1%
|
13
+6.8%
|
15
+15.0%
|
14
+17.8%
|
| Operating expenses |
9
|
10
|
10
|
12
-28.1%
|
—
|
—
|
—
|
17
+1.2%
|
| Operating income |
-6
+45.2%
|
-7
+59.0%
|
-7
+61.5%
|
-10
+32.0%
|
-10
+30.4%
|
-17
-13.5%
|
-17
-21.5%
|
-15
-3.5%
|
| Other income (expense) |
-1
|
-1
|
—
|
—
|
—
|
—
|
—
|
—
|
| Pretax income |
-6
+43.5%
|
-8
+56.8%
|
-7
+58.9%
|
-12
+22.1%
|
-11
-3.9%
|
-17
-12.3%
|
-18
-19.6%
|
-16
-0.8%
|
| Net income |
-6
+41.4%
|
-8
+55.6%
|
-7
+58.4%
|
-7
+56.0%
|
-11
-0.2%
|
-17
-9.3%
|
-18
-16.9%
|
-15
+1.0%
|
| Basic EPS |
-13.44
+41.9%
|
-15.77
+56.2%
|
-0.08
+57.9%
|
-0.07
+56.2%
|
-23.15
-19727.7%
|
-36.02
-7563.8%
|
-0.19
+66.7%
|
-0.16
|
| Diluted EPS |
-13.44
+41.9%
|
-15.77
+56.2%
|
-0.08
+57.9%
|
-0.07
+56.2%
|
-23.15
-19727.7%
|
-36.02
-7563.8%
|
-0.19
+66.7%
|
-0.16
|
| Weighted average shares, basic |
0
+0.8%
|
0
+1.4%
|
95
+1.9%
|
95
+1.5%
|
0
-99.5%
|
0
-98.6%
|
94
+253.9%
|
93
|
| Weighted average shares, diluted |
0
+0.8%
|
0
+1.4%
|
95
+1.9%
|
95
+1.5%
|
0
-99.5%
|
0
-98.6%
|
94
+253.9%
|
93
|
| Other measures | ||||||||
| Depreciation and amortization |
0
+212.5%
|
0
-80.2%
|
0
-80.3%
|
0
-81.1%
|
0
-92.2%
|
0
+43.8%
|
0
+60.6%
|
0
+37.8%
|
| EBITDA |
-6
+45.8%
|
-7
+58.5%
|
-7
+61.1%
|
-10
+30.8%
|
-10
+29.1%
|
-16
-12.9%
|
-17
-20.9%
|
-15
-2.9%
|
| Interest coverage |
-6.53x
|
-6.72x
|
—
|
—
|
—
|
—
|
—
|
—
|
| Margins | ||||||||
| Gross margin |
41.12%
|
41.19%
|
37.48%
|
28.40%
|
25.40%
|
10.83%
|
-5.53%
|
22.79%
|
| Operating margin |
-67.89%
|
-84.52%
|
-80.43%
|
-145.44%
|
-113.91%
|
-202.93%
|
-198.08%
|
-173.58%
|
| Pretax margin |
-76.69%
|
-93.78%
|
-89.56%
|
-172.97%
|
-124.92%
|
-213.76%
|
-206.52%
|
-180.25%
|
| Profit margin |
-76.70%
|
-93.78%
|
-88.59%
|
-95.96%
|
-120.55%
|
-208.01%
|
-201.87%
|
-177.13%
|
| EBITDA margin |
-66.98%
|
-83.57%
|
-79.55%
|
-144.53%
|
-113.64%
|
-198.22%
|
-193.85%
|
-169.67%
|
How these figures are calculated
Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. More on our methodology.
New to this? Read How to Read an Income Statement, With a Real Example.
Company profile
- Industry
- Dental Equipment & Supplies (SIC 3843)
- Listed as
- SONX (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Laguna Hills, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1407973
- Former names
- Dentatek CORP (until Dec 1, 2010)
Other Dental Equipment & Supplies companies
- Envista Holdings Corp NVST
- DENTSPLY SIRONA Inc. XRAY
- Dror Ortho-Design, Inc. DROR
- Standard Dental Labs Inc. TUTH
Source: SEC EDGAR filings. This is company-reported data, not investment advice.